Commentary: Maternal immune activation evoked by polyinosinic: Polycytidylic acid does not evoke microglial cell activation in the embryo

Frontiers in Cellular Neuroscience

Volumn 10, Issue FEB, 2016, Pages

  Bernstein, Hans Gert ^a   Piontkewitz, Yael ^b   Keilhoff, Gerburg ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Astrocytes; Maternal immune activation; Microglia; Offspring; Poly I:C

Indexed keywords

POLYINOSINIC POLYCYTIDYLIC ACID; STROMELYSIN; TOLL LIKE RECEPTOR 3;

ASTROCYTE; BEHAVIOR CHANGE; CELL ACTIVATION; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INTRAUTERINE INFECTION; MENTAL DISEASE; MICROGLIA; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NONHUMAN; NOTE; PREGNANCY; PROGENY; PROTEIN EXPRESSION; SCHIZOPHRENIA;

EID: 84960124099     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2015.00301     Document Type: Note

References (29)

1. Cunningham, C. (2013). Microglia and neurodegeneration: the role of systemic inflammation. Glia 61, 71–90. doi: 10.1002/glia.22350
2. Dean, J. M., Shi, Z., Fleiss, B., Gunn, K. C., Groenendaal, F., van Bel, F., et al. (2015). A critical review of models of perinatal infection. Dev. Neurosci. 37, 289–304. doi: 10.1159/000370309
3. Deleidi, M., Hallett, P. J., Koprich, J. B., Chung, C. Y., and Isacson, O. (2010). The Toll-like receptor-3 agonist polyinosinic:polycytidylic acid triggers nigrostriatal dopaminergic degeneration. J. Neurosci. 30, 16091–16101. doi: 10.1523/JNEUROSCI.2400-10.2010
4. De Miranda, J., Yaddanapudi, K., Hornig, M., Villar, G., Serge, R., and Lipkin, W. I. (2010). Induction of Toll-like receptor 3-mediated immunity during gestation inhibits cortical neurogenesis and causes behavioral disturbances. MBio 1, e00176–e00110. doi: 10.1128/mbio.00176-10
5. Farina, C., Krumbholz, M., Giese, T., Hartmann, G., Aloisi, F., and Meinl, E. (2005). Preferential expression and function of Toll-like receptor 3 in human astrocytes. J. Neuroimmunol. 159, 12–19. doi: 10.1016/j.jneuroim.2004.09.009
6. Farina, C., Aloisi, F., and Meinl, E. (2007). Astrocytes are active players in cerebral innate immunity. Trends. Immunol. 28, 138–145. doi: 10.1016/j.it.2007.01.005
7. Giovanoli, S., Notter, T., Richetto, J., Labouesse, M. A., Vuillermot, S., Riva, M. A., et al. (2015a). Late prenatal immune activation causes hippocampal deficits in the absence of persistent inflammation across aging. J. Neuroinflammation 12, 221. doi: 10.1186/s12974-015-0437-y
8. Giovanoli, S., Weber-Stadlbauer, U., Schedlowski, M., Meyer, U., and Engler, H. (2015b). Prenatal immune activation causes hippocampal synaptic deficits in the absence of overt microglia anomalies. Brain. Behav. Immunity. doi: 10.1016/j.bbi.2015.09.015. [Epub ahead of print].
9. Grelier, A., Cras, A., Balitrand, N., Delmau, C., Lecourt, S., Lepelletier, Y., et al. (2013). Toll-like receptor 3 regulates cord blood-derived endothelial cell function in vitro and in vivo. Angiogenesis 16, 821–836. doi: 10.1007/s10456-013-9358-5
10. Ibi, D., Nagai, T., Nakajima, A., Mizoguchi, H., Kawase, T., Tsuboi, D., et al. (2013). Astroglial IFITM3 mediates neuronal impairments following neonatal immune challenge in mice. Glia 61, 679–693. doi: 10.1002/glia.22461
11. Ibi, D., and Yamada, K. (2015). Therapeutic targets for neurodevelopmental disorders emerging from animal models with perinatal immune activation. Int. J. Mol. Sci. 16, 28218–28229. doi: 10.3390/ijms161226092
12. Juckel, G., Manitz, M. P., Brüne, M., Friebe, A., Heneka, M. T., and Wolf, R. J. (2011). Microglial activation in a neuroinflammational animal model of schizophrenia—a pilot study. Schizophr. Res. 131, 96–100. doi: 10.1016/j.schres.2011.06.018
13. Meyer, U., Feldon, J., Schedlowski, M., and Yee, B. K. (2005). Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci. Biobehav. Rev. 29, 913–947. doi: 10.1016/j.neubiorev.2004.10.012
14. Meyer, U., Feldon, J., and Fatemi, S. H. (2009). In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders. Neurosci Biobehav. Rev. 33, 1061–1079. doi: 10.1016/j.neubiorev.2009.05.001
15. Missault, S., Van den Eynde, K., Vanden Berghe, W., Fransen, E., Weeren, A., Timmermans, J. P., et al. (2014). The risk for behavioural deficits is determined by the maternal immune response to prenatal immune challenge in a neurodevelopmental model. Brain Behav Immun. 42, 138–146. doi: 10.1016/j.bbi.2014.06.013
16. Olson, J. K., and Miller, S. D. (2004). Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 173, 3916–3924. doi: 10.4049/jimmunol.173.6.3916
17. Park, C., Lee, S., Cho, I. H., Lee, H. K., Kim, D., Choi, S. Y., et al. (2006). TLR3-mediated signal induces proinflammatory cytokine and chemokine gene expression in astrocytes: differential signaling mechanisms of TLR3-induced IP-10 and IL-8 gene expression. Glia 53, 248–256. doi: 10.1002/glia.20278
18. Patro, I. K., Amit, S. M., Bhumika, S., and Patro, N. (2010). Poly I:C induced microglial activation impairs motor activity in adult rats. Indian J. Exp. Biol. 48, 104–109.
19. Piontkewitz, Y., Bernstein, H. G., Dobrowolny, H., Bogerts, B., Weiner, I., and Keilhoff, G. (2012). Effects of risperidone treatment in adolescence on hippocampal neurogenesis, parvalbumin expression, and vascularization following prenatal immune activation in rats. Brain Behav. Immun. 26, 353–363. doi: 10.1016/j.bbi.2011.11.004
20. Ratnayake, U., Quinn, T. A., Castillo-Melendez, M., Dickinson, H., and Walker, D.W. (2012). Behaviour and hippocampus-specific changes in spiny mouse neonates after treatment of the mother with the viral-mimetic Poly I:C at mid-pregnancy. Brain. Behav. Immun. 26, 1288–1299. doi: 10.1016/j.bbi.2012.08.011
21. Roumier, A., Pascual, O., Béchade, C., Wakselman, S., Poncer, J. C., Réal, E., et al. (2008). Prenatal activation of microglia induces delayed impairment of glutamatergic synaptic function. PLoS ONE 3:e2595. doi: 10.1371/journal.pone.0002595
22. Shi, H., Gabarin, N., Hickey, E., and Askalan, R. (2013). TLR-3 receptor activation protects the very immature brain from ischemic injury. J. Neuroinflammation 10:104. doi: 10.1186/1742-2094-10-104
23. Smolders, S., Smolders, S. M., Swinnen, N., Gärtner, A., Rigo, J. M., Legendre, P., et al. (2015). Maternal immune activation evoked by polyinosinic: polycytidylic acid does not evoke microglial cell activation in the embryo. Front. Cell. Neurosci. 9:301. doi: 10.3389/fncel.2015.00301
24. Van den Eynde, K., Missault, S., Fransen, E., Raeymaekers, L., Willems, R., Drinkenburg, W., et al. (2014). Hypolocomotive behaviour associated with increased microglia in a prenatal immune activation model with relevance to schizophrenia. Behav. Brain Res. 258, 179–186. doi: 10.1016/j.bbr.2013.10.005
25. Yamada, S., Nagai, T., Nakai, T., Ibi, D., Nakajima, A., and Yamada, K. (2014). Matrix metalloproteinase-3 is a possible mediator of neurodevelopmental impairment due to polyI:C-induced innate immune activation of astrocytes. Brain. Behav. Immun. 38, 272–282. doi: 10.1016/j.bbi.2014.02.014
26. Zager, A., Peron, J. P., Mennecier, G., Rodrigues, S. C., Aloia, T. P., and Palermo-Neto, J. (2015). Maternal immune activation in late gestation increases neuroinflammation and aggravates experimental autoimmune encephalomyelitis in the offspring. Brain Behav. Immun. 43, 159–171. doi: 10.1016/j.bbi.2014.07.021
27. Zhang, Z., and van Praag, H. (2015). Maternal immune activation differentially impacts mature and adult-born hippocampal neurons in male mice. Brain. Behav. Immun. 45, 60–70. doi: 10.1016/j.bbi.2014.10.010
28. Zhu, F., Zheng, Y., Liu, Y., Zhang, X., and Zhao, J. (2014). Minocycline alleviates behavioral deficits and inhibits microglial activation in the offspring of pregnant mice after administration of polyriboinosinic-polyribocytidilic acid. Psychiatry Res. 219, 680–686. doi: 10.1016/j.psychres.2014.06.046
29. Zuckerman, L., Rehavi, M., Nachman, R., and Weiner, I. (2003). Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacology 28, 1778–1789. doi: 10.1038/sj.npp.1300248